We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Poor soil

16 October 2020 By Aimee Donnellan

Britain’s watchdog has opened the door for medicinal marijuana companies to be listed in London. Success stories may, however, end up following GW Pharmaceuticals, which in 2016 opted to list solely in New York after more than a decade of seeing its share price stagnate.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)